These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22847566)

  • 61. Vancomycin monotherapy vs. combination therapy for the treatment of persistent methicillin-resistant Staphylococcus aureus bacteremia.
    Seah J; Lye DC; Ng TM; Krishnan P; Choudhury S; Teng CB
    Virulence; 2013 Nov; 4(8):734-9. PubMed ID: 24165210
    [No Abstract]   [Full Text] [Related]  

  • 62. Impact of area under the concentration-time curve to minimum inhibitory concentration ratio on vancomycin treatment outcomes in methicillin-resistant Staphylococcus aureus bacteraemia.
    Song KH; Kim HB; Kim HS; Lee MJ; Jung Y; Kim G; Hwang JH; Kim NH; Kim M; Kim CJ; Choe PG; Chung JY; Park WB; Kim ES; Park KU; Kim NJ; Kim EC; Oh MD
    Int J Antimicrob Agents; 2015 Dec; 46(6):689-95. PubMed ID: 26555059
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evaluation of vancomycin population susceptibility analysis profile as a predictor of outcomes for patients with infective endocarditis due to methicillin-resistant Staphylococcus aureus.
    Casapao AM; Davis SL; McRoberts JP; Lagnf AM; Patel S; Kullar R; Levine DP; Rybak MJ
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4636-41. PubMed ID: 24890596
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Growing Resistance to Vancomycin among Methicillin Resistant Staphylococcus Aureus Isolates from Different Clinical Samples.
    Pahadi PC; Shrestha UT; Adhikari N; Shah PK; Amatya R
    JNMA J Nepal Med Assoc; 2014; 52(196):977-81. PubMed ID: 26982895
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Daptomycin versus vancomycin for osteoarticular infections due to methicillin-resistant Staphylococcus aureus (MRSA): a nested case-control study.
    Liang SY; Khair HN; McDonald JR; Babcock HM; Marschall J
    Eur J Clin Microbiol Infect Dis; 2014 Apr; 33(4):659-64. PubMed ID: 24186726
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Trends in incidence and susceptibility among methicillin-resistant Staphylococcus aureus isolated from intranasal cultures associated with rhinosinusitis.
    Rujanavej V; Soudry E; Banaei N; Baron EJ; Hwang PH; Nayak JV
    Am J Rhinol Allergy; 2013; 27(2):134-7. PubMed ID: 23562203
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treatment of methicillin-resistant Staphylococcus aureus: vancomycin and beyond.
    Holmes NE; Tong SY; Davis JS; van Hal SJ
    Semin Respir Crit Care Med; 2015 Feb; 36(1):17-30. PubMed ID: 25643268
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Use of ceftaroline after glycopeptide failure to eradicate meticillin-resistant Staphylococcus aureus bacteraemia with elevated vancomycin minimum inhibitory concentrations.
    Paladino JA; Jacobs DM; Shields RK; Taylor J; Bader J; Adelman MH; Wilton GJ; Crane JK; Schentag JJ
    Int J Antimicrob Agents; 2014 Dec; 44(6):557-63. PubMed ID: 25282169
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches.
    Holubar M; Meng L; Alegria W; Deresinski S
    Infect Dis Clin North Am; 2020 Dec; 34(4):849-861. PubMed ID: 33011050
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Predictive Value of the Methicillin-Resistant
    Stodghill J; Finnigan A; Newcomb AB; Lita E; Liu C; Teicher E
    Surg Infect (Larchmt); 2021 Nov; 22(9):889-893. PubMed ID: 33872057
    [No Abstract]   [Full Text] [Related]  

  • 71. High prevalence of isolates with reduced glycopeptide susceptibility in persistent or recurrent bloodstream infections due to methicillin-resistant Staphylococcus aureus.
    Uçkay I; Bernard L; Buzzi M; Harbarth S; François P; Huggler E; Ferry T; Schrenzel J; Renzoni A; Vaudaux P; Lew DP
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1258-64. PubMed ID: 22155824
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Outcomes of Vancomycin plus a β-Lactam versus Vancomycin Only for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.
    Truong J; Veillette JJ; Forland SC
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133561
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cathodic Voltage-controlled Electrical Stimulation Plus Prolonged Vancomycin Reduce Bacterial Burden of a Titanium Implant-associated Infection in a Rodent Model.
    Nodzo SR; Tobias M; Ahn R; Hansen L; Luke-Marshall NR; Howard C; Wild L; Campagnari AA; Ehrensberger MT
    Clin Orthop Relat Res; 2016 Jul; 474(7):1668-75. PubMed ID: 26801677
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Characterization of SCCmec and spa types of methicillin-resistant Staphylococcus aureus isolates from health-care and community-acquired infections in Kerman, Iran.
    Fasihi Y; Kiaei S; Kalantar-Neyestanaki D
    J Epidemiol Glob Health; 2017 Dec; 7(4):263-267. PubMed ID: 29110867
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Can Nasal Methicillin-Resistant Staphylococcus aureus Screening Be Used to Avoid Empiric Vancomycin Use in Intra-Abdominal Infection?
    Hennessy SA; Shah PM; Guidry CA; Davies SW; Hranjec T; Sawyer RG
    Surg Infect (Larchmt); 2015 Aug; 16(4):396-400. PubMed ID: 26069990
    [TBL] [Abstract][Full Text] [Related]  

  • 76. More accurate measurement of vancomycin minimum inhibitory concentration indicates poor outcomes in meticillin-resistant Staphylococcus aureus bacteraemia.
    Shoji H; Maeda M; Shirakura T; Takuma T; Ugajin K; Fukuchi K; Ishino K; Niki Y
    Int J Antimicrob Agents; 2015 Nov; 46(5):532-7. PubMed ID: 26364848
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Combination Therapy With Vancomycin and Ceftaroline for Refractory Methicillin-resistant Staphylococcus aureus Bacteremia: A Case Series.
    Gritsenko D; Fedorenko M; Ruhe JJ; Altshuler J
    Clin Ther; 2017 Jan; 39(1):212-218. PubMed ID: 28038791
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA.
    Horne KC; Howden BP; Grabsch EA; Graham M; Ward PB; Xie S; Mayall BC; Johnson PD; Grayson ML
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3447-52. PubMed ID: 19506056
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia.
    Walraven CJ; North MS; Marr-Lyon L; Deming P; Sakoulas G; Mercier RC
    J Antimicrob Chemother; 2011 Oct; 66(10):2386-92. PubMed ID: 21775337
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation.
    Moise PA; Culshaw DL; Wong-Beringer A; Bensman J; Lamp KC; Smith WJ; Bauer K; Goff DA; Adamson R; Leuthner K; Virata MD; McKinnell JA; Chaudhry SB; Eskandarian R; Lodise T; Reyes K; Zervos MJ
    Clin Ther; 2016 Jan; 38(1):16-30. PubMed ID: 26585355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.